WEEK 40 SUMMARY

Hello guys!

We close the first week of October with a + 0.82% compared to + 0.12% on the Nasdaq.

After an uncertain start on Monday, we are able to recover during the week and close positively. Obviously we are far from recovering the heavy losses suffered in the month of September.

Friday's disappointing data on employment growth which showed a slowdown last month in the United States, with 194,000 nonfarm jobs created compared to 366,000 in August and 500,000 forecast according to the Reuters consensus, prompted the nasdaq to 15,000 points to then close the session with a loss of 0.51%.

Net job creation was well below expectations in September, which was not enough to convince investors that the Federal Reserve could delay a slowdown. It could be a weekend profit taking, however, as we await market behavior this week and future tapering news.

In the meantime, the risk of default has also been averted, for the moment, with an increase in the public debt ceiling at least until December.

Fears therefore seem to be starting to calm down and this could lead to the year-end rally we are looking forward to so long. Now all that remains is to break the psychological resistance of 15000 points to head towards the maximum of 15400.

Now let's see our TOP & FLOP from the first week of October

TOP 3

1. DOYU + 12.22%

2. NIU + 9.74%

3. COIN + 7.35%

Chinese companies rebounded after the evergrande shock caused them to sink further in September by 22% and 18%.

Coinbase follows the trend of cryptocurrencies, bullish in this start of the month even if it fails to exceed the 250$ threshold.

FLOP 3

1. COCP -6.86%

2. BYND - 4.26%

3. CSIQ - 4.04%

No major news justified this correction, BYND hit $ 100 and could be strong support, COCP probably the absence of news on its COVID vaccine is leading investors to abandon ship. However, we must not forget that it is a company that is developing other types of vaccines. For the moment the most advanced (phase 2A) is that on type C hepatitis. In total it has 6 vaccines under study.

During the week I have not closed any positions, I believe that the market is underestimating several companies and I therefore plan to keep them for a longer time. I took the opportunity to open a position in NIO and PLTR, two companies that I personally love, I think NIO is interesting for 1-2 years, while PLTR I find it super interesting to monitor for at least 10 years.

Hoping for a good week, I invite you to follow me and why not even copy me:

R𝗮𝗻𝗸 𝘀𝘁𝗮𝗿𝘁 𝗰𝗼𝗽𝘆: 𝟴 / 𝟭𝟬 - Also this week my advice is to start copying if you are interested because the market conditions are optimal. The sooner you start copying, the more you will be able to take advantage of our portfolio growth.

That's all for this week too, I want to thank again for the confidence given to me also in this period of strong correction. Your patience will be rewarded!

Goodbye and happy Sunday everyone!